Concepedia

Erika A. Currier

EA

Statistics

Publications

20

Citations

982

H-Index

17

Active since

1998

Affiliations

Acadia Pharmaceuticals (United States)(Current)

Ideon Science Park

Medeon

University of Gothenburg

University of California San Diego

Erika A. Currier is an author at Acadia Pharmaceuticals (United States) specializing in pharmacology, drug discovery, and ligand binding.

Publications per year

1998–2013

20

Publications

20

5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics

David M. Weiner, Ethan S. Burstein, N. T. Nash et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 202 citations

, , +17

Discovery of an Ectopic Activation Site on the M<sub>1</sub>Muscarinic Receptor

Tracy A. Spalding, Carol Trotter, Niels Skjærbæk et al. · Molecular Pharmacology · 2002 · 187 citations

, , +17

Discovery of the First Nonpeptide Agonist of the GPR14/Urotensin-II Receptor:  3-(4-Chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)

Glenn Croston, Roger Olsson, Erika A. Currier et al. · Journal of Medicinal Chemistry · 2002 · 66 citations · Full text

, , +12

Discovery of a Potent, Orally Available, and Isoform-Selective Retinoic Acid β2 Receptor Agonist

Birgitte W. Lund, Fabrice Piu, Natalie K. Gauthier et al. · Journal of Medicinal Chemistry · 2005 · 65 citations · Full text

, , +17

Design, parallel synthesis and SAR of novel urotensin II receptor agonists

Fredrik Lehmann, Lisa Lake, Erika A. Currier et al. · European Journal of Medicinal Chemistry · 2006 · 44 citations · Full text

, , +14

1–5 of 20